Acute myeloid leukemia (AML) is a common hematological malignant tumor in children. AML is characterized by high morbidity, recurrence and mortality rates worldwide. Immune cell infiltration in tumor microenvironment plays an important role in tumor progression. This study aimed at exploring biomarkers related to CD8+T cell infiltration in children with AML. Transcriptome data and clinical data were retrieved from TARGET database. We collected whole blood samples from some AML children to verify the results. Through the joint analysis of the data of multiple databases we found that CAMK2D, MPZL3, MSL3 are associated with CD8+ immune infiltration. Through PCR analysis, it was found that CAMK2D, MPZL3, MSL3 was highly expressed in the whole blood of children with AML. Analysis showed that CAMK2D, MPZL3 and MSL3 are potential clinical prognostic markers related to CD8+T cell infiltration in children with AML. The findings of this study show that CAMK2D, MPZL3, MSL3 are implicated in prognosis of AML. Notably, the three genes are implicated in CD8+T cells-related pathways.